Champions Oncology Inc expected to post a loss of 4 cents a share - Earnings Preview

Champions Oncology

10/03/2023 22:43

* Champions Oncology Inc  CSBR.OQ   CSBR.O  is expected
to show a
fall in quarterly revenue when it reports  results on March 13
(estimated). 
    * The Baltimore Maryland-based  company is expected to
report  a
0.5% decrease in revenue to $13.133 million from $13.19 million
a year ago, according to the mean estimate from 3 analysts,
based on Refinitiv data. 
    * ​Refinitiv's mean analyst estimate for Champions Oncology
Inc is
for a loss of 4 cents per share. 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 3 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Champions
Oncology Inc is $12​, above​ its last closing price of $4.49.
​​​

Previous quarterly performance (using preferred earnings measure
in US dollars). ​
 QUARTER       STARMINESM  REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  IBES                 MET,    SE %
               E®          ESTIMATE             MISSED  
 Oct. 31 2022  -0.01       -0.01      0.00      Beat    100
 Jul. 31 2022  0.01        0.01       -0.02     Missed  -300
 Apr. 30 2022              0.03       -0.03     Missed  -220​
 Jan. 31 2022  0.02        0.03       0.05      Beat    100
 ​​Oct.        0.01        0.01       0.02      Beat    300
 31 2021                                                
 Jul. 31 2021  0.01        0.01       -0.01     Missed  -200​
 Apr. 30 2021  0.00        0.00       -0.04     Missed  
 Jan. 31 2021  0.00        0.01       0.05      Beat    649.6
 This summary was machine generated March 10 at 22:43 GMT.  All
figures in US dollars  unless otherwise stated